Testosterone for perimenopause: what TikTok gets wrong

What's this video probably claiming?

Based on the caption and hashtag combination, @hrtandme5 is almost certainly walking viewers through testosterone as part of a broader hormone optimization conversation for perimenopausal women. These videos tend to follow a familiar script: fatigue, low libido, brain fog, and mood changes are framed as testosterone deficiency problems, and HRT, specifically formulations that include T alongside estrogen and progesterone, is presented as the missing piece midlife women aren't being told about. The creator is likely speaking from personal experience, which is fine as far as it goes. The problem is that personal experience tends to compress nuance. Viewers walk away with the impression that testosterone is an obvious, low-risk add-on to standard menopause care, when the clinical picture is considerably more complicated. TikTok's format rewards confident takes, not caveats.

What does the science actually show?

Testosterone in women is genuinely understudy and the data are more interesting than either skeptics or enthusiasts admit. The Global Consensus Position Statement on testosterone therapy for women (Davis et al., 2019, Journal of Clinical Endocrinology and Metabolism) concluded that there is evidence supporting testosterone for postmenopausal women with hypoactive sexual desire disorder, with the caveat that physiological dosing matters enormously. A 2021 systematic review by Islam et al. in The Lancet Diabetes and Endocrinology found that transdermal testosterone improved sexual function scores by a meaningful margin over placebo across 8 randomized trials. However, the same review found no adequately powered, long-term safety data beyond 24 months. Claims about testosterone improving cognition, mood, or energy in perimenopausal women specifically rest on much weaker evidence. Most positive trials enrolled postmenopausal women, and extrapolating those findings to perimenopause, where endogenous hormone levels are still fluctuating, is a clinical stretch.

Where does the social media noise diverge from clinical reality?

The biggest disconnect is around dosing and formulation. TikTok content almost never distinguishes between physiological female dosing and the testosterone cypionate doses used in male TRT protocols. Female physiological testosterone levels run roughly 15 to 70 ng/dL. Male TRT protocols typically target 400 to 700 ng/dL or higher. When creators talk about testosterone without that distinction, the audience has no way to assess what they are actually being advised toward. Compounded testosterone creams are widely discussed on these platforms as interchangeable with FDA-approved options. They are not. Compounded products lack standardized bioavailability data, and the FDA has not approved any testosterone product specifically for women in the United States, which means every female T prescription is already off-label. That context rarely makes it into a 60-second TikTok. Pellet therapy is also frequently promoted in this content category despite having the least dose-control flexibility of any delivery method, a real concern if levels go supraphysiological.

What should you actually know?

If you are a perimenopausal woman experiencing symptoms attributed to low testosterone, the first step is an actual measurement, not a symptom checklist from a content creator. Free testosterone and SHBG levels matter as much as total testosterone. Symptoms like fatigue and brain fog have a long differential diagnosis list, and androgens are not the default explanation. If testosterone is clinically indicated, the Davis 2019 consensus recommends targeting the physiological premenopausal range, not male reference ranges. Monitoring for androgenic side effects, including acne, hair changes, and voice changes, is standard practice and should happen at regular intervals. The FDA's lack of an approved female testosterone product means patients need to understand they are working in an off-label space, which requires a prescriber who knows how to manage it, not just one who is willing to prescribe it. A regulated telehealth platform with clinical oversight is meaningfully different from following a TikTok protocol.